Cellumen, a discovery toxicology company,
creates Cellular Systems Biology(CSB™)
products & services that accelerate the
progression of novel therapies from the
discovery laboratory through the clinic.
FEATURED PRESS RELEASE:
Cellumen Collaborates
with the NCTR of the FDA to Apply Cellular
Systems Biology to Predictive Toxicology
CellCiphr®
Cellular Models of Disease
CSB™ reagents, assays and profiles enable better lead generation.
CellCiphr®
Toxicity Profiling
CSB™ reagents, assays and profiles enable identification of toxic liabilities early in discovery.
CellCiphr®
Patient Sample Profiling
CSB™ reagents, assays and profiles enable better patient stratification.
CSB™ is the new force in bringing drugs to market.
Cellumen's CellCiphr products and services include advanced reagents to measure and manipulate cell function, panels of reagents and assays to profile cellular models of disease and toxicity, and a developing program of Patient Sample Profiling.
Cellumen offers products, services and partnerships.
Learn more about CellCiphr Products & Services »
22
Apr 09 |
|
2
Apr 09 |
Cellumen and Alzheimer's Drug Discovery Foundation Announce New Novel Alzheimer's Screening Tool |
26
Mar 09 |
Cellumen Appoints Dr. Jack A. Reynolds to Board of Directors |
Join our informative Cellumen Webinars on Cellular Systems Biology.
View All Webinars and Register » 
Library
Contact Us